Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Hoosier Cancer Research Network
Hoosier Cancer Research Network
BicycleTx Limited
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Eli Lilly and Company
Revolution Medicines, Inc.
USWM, LLC (dba US WorldMeds)
Actuate Therapeutics Inc.
Pfizer
Incyte Corporation
Mirati Therapeutics Inc.
AstraZeneca
National Cancer Institute (NCI)
GlaxoSmithKline
Mayo Clinic
Novartis
Boehringer Ingelheim
Eli Lilly and Company
Tomsk National Research Medical Center of the Russian Academy of Sciences
Daiichi Sankyo
AstraZeneca
Genentech, Inc.
University of Oklahoma
Werewolf Therapeutics, Inc.
Pierre Fabre Medicament
AstraZeneca
City of Hope Medical Center
AbbVie
NovoCure Ltd.
AstraZeneca
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Turning Point Therapeutics, Inc.
Immuneering Corporation
Sensei Biotherapeutics, Inc.
BeiGene
Daiichi Sankyo
Verastem, Inc.
Hummingbird Bioscience
National Cancer Institute (NCI)
Mirati Therapeutics Inc.
Immunophotonics, Inc.
Carisma Therapeutics Inc
NextCure, Inc.
Bristol-Myers Squibb
Salubris Biotherapeutics Inc
NeoImmuneTech
Adaptimmune